侵袭性真菌感染(ifi)是一种十分严重的造血干细胞移植(HSCT)并发症，以念珠菌属和曲霉菌属感染最常见。
Invasive fungal infections (IFI) are a kind of the most severe complications after hematopoietic stem cell transplantation (HSCT), Candida and Aspergillus are common causes.
背景：对于造血干细胞同种异体移植，当不能得到匹配的同胞供体时，一份库存的供体脐带血可能是很有价值的资源。
BACKGROUND: a stored cord blood donation may be a valuable source of hemopoietic stem cells for allogeneic transplantation when a matched sibling donor is not available.
电离辐射在工业、医学的广泛应用可造成机体严重造血损伤，造血干细胞移植是救治的重要措施。
The application of ionizing radiation to industry, medicine may lead to severe hematopoietic injuries, while hematopoietic stem cells transplantation is the important therapy.
背景：移植后造血干细胞的顺利归巢是单倍相合骨髓移植成功的关键。
BACKGROUND: Successful homing of haemopoietic stem cells is the key step for the success of haploidentical bone marrow transplantation.
造血干细胞移植是治愈重型再障的主要手段，同基因造血干细胞移植也适合慢性再障。
Severe aplastic anemia can be cured by haematopoietic stem cell transplantation. Synegenic HSCT is the best choice for severe aplastic anemia and chronic aplastic anemia.
卡泊芬净一线治疗异基因造血干细胞移植患者侵袭性真菌病是有效且可耐受的。
Caspofungin first-line therapy was effective and well tolerated in allogeneic hematopoietic SCT patients with mycologically documented IA.
同胞捐赠者的造血干细胞移植之前的预处理方案中使用抗胸腺细胞球蛋白一直是有争议的。
The use of antithymocyte globulin in a conditioning regimen prior to hematopoietic stem cell transplantation with a sibling donor has been controversial.
侵袭性真菌感染(ifi)是恶性血液病、长时间中性粒细胞减少或造血干细胞移植后患者重要的发病和死亡原因之一。
Invasive fungal infection (IFI) is an important cause of morbidity and mortality in patients with hematologic malignancy, prolonged neutropenia, or after hematopoietic stem cell transplant.
骨髓移植是患者的造血干细胞被来自供体的代替，一些血癌患者用来治愈他们的疾病。
Bone marrow transplants, in which a patient's blood stem cells are replaced with those from a donor, are given to some patients with blood cancer to cure their disease.
异基因造血干细胞移植是一种高风险的治疗过程。
Allogeneic stem cell transplant can be a high-risk procedure.
自体造血干细胞移植是指用患者自身的干细胞进行移植。
Autologous means the patient's own cells are used for the transplant.
异基因造血干细胞移植是目前唯一可以治愈慢粒的疗法，在年轻患者中尤为成功。
Allogeneic stem cell transplantation is the only treatment that can cure CML at this time. This treatment is most successful in younger patients.
对于临床医生来说，造血干细胞移植(HSCT)后，早期检测移植存活是极其重要的。
After hematopoietic stem cell transplantation (HSCT), early detection of engraftment would be of critical value for clinicians.
尽早诊断、合理治疗；异基因外周血造血干细胞移植是提高该病患儿生存期的关键。
Early diagnosis and rational treatment, allogeneic hematopoietic stem cell transplantation in particular, are the key to the prolongation of survival time of children with erythroleukemia.
造血干细胞移植(有时也称为骨髓移植)，是治疗急性髓细胞白血病的一种手段。
A stem cell transplant (sometimes called a bone marrow transplant) is a treatment used for some patients who have AML.
造血干细胞是骨髓移植治疗中的有效成份，它可分化成各种类型的成熟血细胞。
In a bone marrow transplant, the "active ingredients" are hematopoietic stem cells, which live in the bone marrow and give rise to all the different kinds of mature blood cells.
白血病患者和进行外周血或骨髓造血干细胞移植的患者，由于自身缺乏巨细胞病毒抗体，给他们输注的成分血必须是巨细胞病毒抗体阴性的。
Patients with leukemia and those undergoing blood or marrow stem cell transplantation, who themselves have no antibodies to CMV, should receive blood components that are negative for CMV antibodies.
另一种可选疗法是二次移植，就是对患者施以供体淋巴细胞输注（即注入的白细胞为来自原造血干细胞供体的淋巴细胞）。
Many CML patients cannot have an allogeneic stem cell transplant. Doctors are studying the use of a patient's own stem cells in these cases. This is called an autologous stem cell infusion .
找出合理的剂量和新的高效低毒的预处理方案是提高造血干细胞移植成功率的关键。
The highly-effective preparative regimens of proper dose and low-toxicity are the key to the successful HSCT.
找出合理的剂量和新的高效低毒的预处理方案是提高造血干细胞移植成功率的关键。
The highly-effective preparative regimens of proper dose and low-toxicity are the key to the successful HSCT.
应用推荐